Search for a report

NORTH AMERICA GLUCOSE MONITORING SYSTEM MARKET FORECAST 2019-2028

  • You are here:
  • Home
  • Downloads
  • NORTH AMERICA GLUCOSE MONITORING SYSTEM MARKET FORECAST 2019-2028

NORTH AMERICA GLUCOSE MONITORING SYSTEM MARKET FORECAST 2019-2028

The North America glucose monitoring system CGMS market is estimated to grow at a CAGR of 21.39%, and the SMBG market is expected to grow at a CAGR of 4.67% over the forecast period of 2019-2028. The crucial factors contributing to the market growth are advanced healthcare infrastructure, and the increasing prevalence of obesity and diabetes.

NORTH AMERICA GLUCOSE MONITORING SYSTEM MARKET FORECAST 2019-2028

North America Glucose Monitoring System Market by Component Type (Sensors, Transmitters and Receivers, Insulin Pump) by End-users (Home Settings, Diagnostics and Clinics, Hospitals) by Demographics (Adult Population (>14years), Child Population (≤14years)) by Component Type (Test Strips, Glucose Meter, Lancets) by End-user (Home Settings, Clinical, Hospital) by Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes) by Geography.

Request free sample

The North America glucose monitoring system CGMS market is estimated to grow at a CAGR of 21.39%, and the SMBG market is expected to grow at a CAGR of 4.67% over the forecast period of 2019-2028. The crucial factors contributing to the market growth are advanced healthcare infrastructure, and the increasing prevalence of obesity and diabetes.
North America Glucose Monitoring System Market

To know more about this report, request a free sample copy

The North America glucose monitoring system market is surveyed by segregating the region into the United States and Canada. In the United States, President Obama and his administration declared their commitment to the prevention of diabetes on 1st November, 2012, by creating a new program. This program encompassed regular diabetes screenings, lifestyle counseling, and diabetes education with no out of pocket costs, with the goal of changing the way diabetes is treated and managed, along with a focus on preventive care. The healthcare reforms brought by the program included the disallowing insurance companies from rejecting children, new insurance plans that would cover certain preventive care services, and businesses with more than 50 employees having to purchase health insurance or face fines. The pharmaceutical market of the US is worth $xx billion, which is expected to grow at a moderate rate of 6% in the immediate future. The country spends almost a considerable amount a year on prescription drugs. The US government spends significantly on biomedical research, which has proved to be extremely beneficial.

Abbott Diagnostic, headquartered in Illinois, is a medical equipment manufacturing company, which offers a range of medical instruments, tests, and systems for clinics and hospitals. In March 2020, the company announced that FDA has issued EUA for the fastest molecular point of care test for the detection of COVID-19.

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

  1. RESEARCH SCOPE & METHODOLOGY
    • STUDY OBJECTIVES
    • SCOPE OF STUDY
    • METHODOLOGY
    • ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARIES
    • MARKET SIZE & ESTIMATES
    • MARKET OVERVIEW
  3. MARKET DYNAMICS
    • MARKET DEFINITION
    •    KEY DRIVERS
      • RISE IN THE INCIDENCE OF DIABETES
      • INCREASING FOCUS ON RESEARCH AND DEVELOPMENT
      • TECHNOLOGY INTEGRATION
      • INCREASING CGMS AND SMBG AFFORDABILITY
      • TECHNOLOGICAL ADVANCES IN GMS DEVICES
      • AWARENESS AMONG THE GENERAL POPULATION
    •    KEY RESTRAINTS
      • HINDRANCE FROM GOVERNMENT REGULATIONS
      • INADEQUATE REIMBURSEMENT OPTIONS FOR CONTINUOUS GLUCOSE MONITORING DEVICES
      • LACK OF AWARENESS OF THE DIAGNOSTIC OPPORTUNITIES
      • INTENSE COMPETITION AMONG VENDORS
      • INACCURACY IN READING OF GMS DEVICES
  1. KEY ANALYTICS
    •    PORTER’S FIVE FORCE ANALYSIS
      • THREAT OF NEW ENTRY
      • THREAT OF SUBSTITUTION
      • BUYER’S POWER
      • SUPPLIER’S POWER
      • COMPETITIVE RIVALRY
    • KEY BUYING CRITERIA
    • REGULATION OF BLOOD SUGAR
    • VALUE CHAIN ANALYSIS
    • OPPORTUNITY MATRIX
    • VENDOR LANDSCAPE
    • KEY INVESTMENT INSIGHTS
  2. CGMS MARKET BY COMPONENT TYPE
    • SENSORS
    • TRANSMITTER AND RECEIVERS
    • INTEGRATED INSULIN PUMPS
  3. CGMS MARKET BY END-USER
    • HOME SETTINGS
    • DIAGNOSTICS AND CLINICAL
    • HOSPITAL
  4. CGMS MARKET BY DEMOGRAPHICS
    • ADULT POPULATION (>14YEARS)
    • CHILD POPULATION (≤14YEARS)
  5. SMBG MARKET OVERVIEW
  6. SMBG MARKET BY COMPONENT TYPE
    • TEST STRIPS
    • GLUCOSE METER
    • LANCETS
  7. SMBG MARKET BY END-USER
    • HOME SETTINGS
    • CLINICAL
    • HOSPITAL
  8. SMBG MARKET BY APPLICATION
    • TYPE 1 DIABETES
    • TYPE 2 DIABETES
    • GESTATIONAL DIABETES
  9. GEOGRAPHICAL ANALYSIS
    •    NORTH AMERICA
      •    THE UNITED STATES
        • THE UNITED STATES HEALTH AND HEALTHCARE
        • THE UNITED STATES PHARMACEUTICAL MARKET
      •    CANADA
        • CANADA HEALTH AND HEALTHCARE
        • CANADA PHARMACEUTICAL MARKET
        • CANADA DIABETES MARKET
  1. COMPANY PROFILES
    • ABBOTT
    • APEX BIOTECHNOLOGY CORPORATION
    • ARKRAY INC
    • ASCENSIA
    • B BRAUN MELSUNGEN AG
    • BECTON DICKINSON AND COMPANY
    • DEXCOM
    • GLYSENS INC
    • INSULET CORP
    • I-SENS INC
    • JOHNSON AND JOHNSON
    • MEDTRONIC
    • MOREPEN LABORATORIES LTD
    • NEMAURA MEDICAL INC
    • ROCHE DIAGNOSTICS
    • SENSEONICS INC
    • TANDEM DIABETES CARE
    • TERUMO
    • WOCKHARDT
    • YPSOMED

LIST OF TABLES  

TABLE 1: MARKET SNAPSHOT – GLUCOSE MONITORING SYSTEM

TABLE 2: DIABETES PREVALENCE IN NORTH AMERICA 2015-2040 (MILLIONS)

TABLE 3: NORTH AMERICA CGMS MARKET, BY COMPONENT TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 4: NORTH AMERICA CGMS MARKET, BY COMPONENT TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 5: NORTH AMERICA CGMS MARKET, BY END-USER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 6: NORTH AMERICA CGMS MARKET, BY END-USER, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 7: NORTH AMERICA CGMS MARKET, BY DEMOGRAPHICS, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 8: NORTH AMERICA CGMS MARKET, BY DEMOGRAPHICS, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 9: IMPORTANT ASPECTS FOR THE USE OF SMBG DEVICES IN HOME-CARE SETTINGS

TABLE 10: SMBG STRIPS USAGE SCENARIO IN SELECTED COUNTRIES IN AMERICAS

TABLE 11: PRODUCT MATRIX FOR LANCETS

TABLE 12: NORTH AMERICA SMBG MARKET, BY COMPONENT TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 13: NORTH AMERICA SMBG MARKET, BY COMPONENT TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 14: NORTH AMERICA SMBG MARKET, BY END-USER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 15: NORTH AMERICA SMBG MARKET, BY END-USER, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 16: NORTH AMERICA SMBG MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 17: NORTH AMERICA SMBG MARKET, BY APPLICATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 18: NORTH AMERICA CGMS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 19: NORTH AMERICA CGMS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 20: NORTH AMERICA SMBG MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 21: NORTH AMERICA SMBG MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)

LIST OF FIGURES

FIGURE 1: PORTER’S FIVE FORCE ANALYSIS

FIGURE 2: VALUE CHAIN OF CGMS MARKET

FIGURE 3: OPPORTUNITY MATRIX

FIGURE 4: VENDOR LANDSCAPE

FIGURE 5: KEY INVESTMENT INSIGHTS

FIGURE 6: NORTH AMERICA CGMS MARKET, BY COMPONENT TYPE, IN 2019

FIGURE 7: NORTH AMERICA CGMS MARKET, BY SENSORS, 2019-2028 (IN $ MILLION)

FIGURE 8: NORTH AMERICA CGMS MARKET, BY TRANSMITTER AND RECEIVERS, 2019-2028 (IN $ MILLION)

FIGURE 9: NORTH AMERICA CGMS MARKET, BY INTEGRATED INSULIN PUMPS, 2019-2028 (IN $ MILLION)

FIGURE 10: NORTH AMERICA CGMS MARKET, BY END-USER, IN 2019

FIGURE 11: NORTH AMERICA CGMS MARKET, BY HOME SETTINGS, 2019-2028 (IN $ MILLION)

FIGURE 12: NORTH AMERICA CGMS MARKET, BY DIAGNOSTICS AND CLINICAL, 2019-2028 (IN $ MILLION)

FIGURE 13: NORTH AMERICA CGMS MARKET, BY HOSPITAL, 2019-2028 (IN $ MILLION)

FIGURE 14: NORTH AMERICA CGMS MARKET, BY DEMOGRAPHICS, IN 2019

FIGURE 15: NORTH AMERICA CGMS MARKET, BY ADULT POPULATION (>14YEARS), 2019-2028 (IN $ MILLION)

FIGURE 16: NORTH AMERICA CGMS MARKET, BY CHILD POPULATION (≤14YEARS), 2019-2028 (IN $ MILLION)

FIGURE 17: NORTH AMERICA SMBG MARKET, BY COMPONENT TYPE, IN 2019

FIGURE 18: NORTH AMERICA SMBG MARKET, BY TEST STRIPS, 2019-2028 (IN $ MILLION)

FIGURE 19: NORTH AMERICA SMBG MARKET, BY GLUCOSE METER, 2019-2028 (IN $ MILLION)

FIGURE 20: NORTH AMERICA SMBG MARKET, BY LANCETS, 2019-2028 (IN $ MILLION)

FIGURE 21: NORTH AMERICA SMBG MARKET, BY END-USER, IN 2019

FIGURE 22: NORTH AMERICA SMBG MARKET, BY HOME SETTINGS, 2019-2028 (IN $ MILLION)

FIGURE 23: NORTH AMERICA SMBG MARKET, BY CLINICAL, 2019-2028 (IN $ MILLION)

FIGURE 24: NORTH AMERICA SMBG MARKET, BY HOSPITAL, 2019-2028 (IN $ MILLION)

FIGURE 25: NORTH AMERICA SMBG MARKET, BY APPLICATION, IN 2019

FIGURE 26: NORTH AMERICA SMBG MARKET, BY TYPE 1 DIABETES, 2019-2028 (IN $ MILLION)

FIGURE 27: NORTH AMERICA SMBG MARKET, BY TYPE 2 DIABETES, 2019-2028 (IN $ MILLION)

FIGURE 28: NORTH AMERICA SMBG MARKET, BY GESTATIONAL DIABETES, 2019-2028 (IN $ MILLION)

FIGURE 29: NORTH AMERICA CGMS MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)

FIGURE 30: NORTH AMERICA SMBG MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)

FIGURE 31: THE UNITED STATES CGMS MARKET, 2019-2028 (IN $ MILLION)

FIGURE 32: THE UNITED STATES SMBG MARKET, 2019-2028 (IN $ MILLION)

FIGURE 33: CANADA CGMS MARKET, 2019-2028 (IN $ MILLION)

FIGURE 34: CANADA SMBG MARKET, 2019-2028 (IN $ MILLION)

  1. GEOGRAPHICAL ANALYSIS
    •    NORTH AMERICA
      •    THE UNITED STATES
        • THE UNITED STATES HEALTH AND HEALTHCARE
        • THE UNITED STATES PHARMACEUTICAL MARKET
      •    CANADA
        • CANADA HEALTH AND HEALTHCARE
        • CANADA PHARMACEUTICAL MARKET
        • CANADA DIABETES MARKET
  1. CGMS MARKET BY COMPONENT TYPE
    • SENSORS
    • TRANSMITTER AND RECEIVERS
    • INTEGRATED INSULIN PUMPS
  2. CGMS MARKET BY END-USER
    • HOME SETTINGS
    • DIAGNOSTICS AND CLINICAL
    • HOSPITAL
  3. CGMS MARKET BY DEMOGRAPHICS
    • ADULT POPULATION (>14YEARS)
    • CHILD POPULATION (≤14YEARS)
  4. SMBG MARKET OVERVIEW
  5. SMBG MARKET BY COMPONENT TYPE
    • TEST STRIPS
    • GLUCOSE METER
    • LANCETS
  6. SMBG MARKET BY END-USER
    • HOME SETTINGS
    • CLINICAL
    • HOSPITAL
  7. SMBG MARKET BY APPLICATION
    • TYPE 1 DIABETES
    • TYPE 2 DIABETES
    • GESTATIONAL DIABETES

To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.



      Choose License Type

      Buy Now